ハンチントン病の世界市場レポート 2025年

ハンチントン病の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR（複合年間成長率）17.8％で10億7,000万米ドルに成長すると予想されます。予測期間中の成長は、神経疾患の有病率の増加、社会的認知度の向上、ヘルスケア支出の増加、研究開発投資の増加、臨床研究活動の拡大などの要因によるものと考えられます。予測期間における主な動向としては、新薬の採用、多数の新薬の開発、革新的技術の出現、技術の進歩、高度な製品に対する需要の高まりなどが挙げられます。

神経疾患の有病率の増加は、今後のハンチントン病市場の拡大を牽引すると予想されます。神経疾患とは、脳、脊髄、神経に影響を及ぼし、運動障害、協調運動障害、感覚障害、認知障害などの症状を引き起こす疾患です。これらの疾患の増加は、人口の高齢化、環境毒素への曝露、ライフスタイルの変化、診断技術の進歩、症例のより良い検出と特定を可能にする遺伝的要因などの要因に起因しています。ハンチントン病は、遺伝子の突然変異によって引き起こされる神経変性疾患であり、運動機能障害、認知機能低下、精神症状を引き起こし、これらはすべて時間の経過とともに徐々に悪化します。例えば、2023年3月、米国を拠点とする非営利健康団体であるアルツハイマー病協会（Alzheimer's Association）は、推定670万人の65歳以上の米国人が現在アルツハイマー型認知症を患っていると報告しています。この病気を予防し、遅らせ、治す画期的な方法がなければ、この数は2060年までに1,380万人に増加する可能性があります。このように神経疾患の有病率が高まっていることが、ハンチントン病市場の拡大に寄与しています。

ハンチントン病市場の企業は、症状を緩和し病気の進行を遅らせるために、経口低分子薬を含む革新的な治療法の創出に注力しています。これらの医薬品は経口摂取可能な低分子化合物であり、タンパク質や酵素などの生物学的標的と相互作用して病気を治療するように設計されています。例えば、2024年9月、米国を拠点とする製薬会社PTC Therapeutics Inc.は、ハンチントン病を標的とするPTC518プログラムについて、米国食品医薬品局（FDA）からファストトラック指定を受けました。この指定は、重要なアンメットメディカルニーズに対応する治療に与えられるもので、PTC518がこの遺伝性疾患を持つ人々の疾患修飾治療薬としての可能性を示すものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のハンチントン病市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のハンチントン病市場：成長率分析
• 世界のハンチントン病市場の実績：規模と成長、2019～2024年
• 世界のハンチントン病市場の予測：規模と成長、2024～2029年、2034年
• 世界のハンチントン病総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のハンチントン病市場：治療の種類別、実績と予測、2019～2024年、2024～2029年、2034年
• 対症療法
• 疾患修飾療法
• その他
• 世界のハンチントン病市場：診断別、実績と予測、2019～2024年、2024～2029年、2034年
• 磁気共鳴画像法（MRI）
• コンピュータ断層撮影（CT）スキャン
• 遺伝子検査
• その他
• 世界のハンチントン病市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 非経口
• その他
• 世界のハンチントン病市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界のハンチントン病市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• ホームケア
• 専門クリニック
• その他
• 世界のハンチントン病市場：対症療法のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 抗精神病薬
• 抗うつ薬
• 気分安定剤
• 筋弛緩剤
• 世界のハンチントン病市場：疾患修飾療法のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 遺伝子サイレンシング療法
• 幹細胞療法
• 神経保護剤
• 世界のハンチントン病市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 理学療法
• 作業療法
• 言語療法

第7章 地域別・国別分析

• 世界のハンチントン病市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のハンチントン病市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ハンチントン病市場：競合情勢
• ハンチントン病市場：企業プロファイル
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Apotex Inc
• Ipsen S.A.
• Vertex Pharmaceuticals Incorporated
• H. Lundbeck A/S
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals PLC
• Lupin Limited.
• Neurocrine Biosciences Inc.
• Alnylam Pharmaceuticals Inc
• PTC Therapeutics Inc.
• Annexon Inc.
• Voyager Therapeutics Inc.
• Stealth BioTherapeutics Corp.
• Vaccinex Inc.
• SOM Biotech S.L.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ハンチントン病市場2029：新たな機会を提供する国
• ハンチントン病市場2029：新たな機会を提供するセグメント
• ハンチントン病市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Huntington's disease is a rare, inherited neurodegenerative condition that causes the gradual degeneration of nerve cells in the brain, resulting in uncontrolled movements, cognitive decline, and emotional disturbances. It is caused by a genetic mutation in the HTT gene and generally manifests in mid-adulthood.

The primary treatment options for Huntington's disease include symptomatic therapy, disease-modifying therapy, and other types of treatments. Symptomatic therapy aims to alleviate symptoms such as movement disorders, psychiatric issues, and cognitive decline, but does not slow the progression of the disease. Diagnosis is made through various methods, including magnetic resonance imaging (MRI), computed tomography (CT) scans, genetic testing, and other diagnostic tools. Medications are delivered through various routes, such as oral, parenteral, and other methods. These drugs are distributed via hospital pharmacies, online pharmacies, and retail pharmacies, and are used by a range of end users, including hospitals, home care services, specialty clinics, and other healthcare providers.

The huntington's disease market research report is one of a series of new reports from The Business Research Company that provides huntington's disease market statistics, including the huntington's disease industry global market size, regional shares, competitors with the huntington's disease market share, detailed huntington's disease market segments, market trends, and opportunities, and any further data you may need to thrive in the huntington's disease industry. This huntington's disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The huntington's disease market size has grown rapidly in recent years. It will grow from $0.47 billion in 2024 to $0.55 billion in 2025 at a compound annual growth rate (CAGR) of 18.1%. The growth during the historic period can be attributed to factors such as heightened awareness of chronic diseases, growing government awareness programs, increased government initiatives to promote awareness of Huntington's disease, a rising geriatric population, and increased research into genetic disorders.

The huntington's disease market size is expected to see rapid growth in the next few years. It will grow to $1.07 billion in 2029 at a compound annual growth rate (CAGR) of 17.8%. The growth during the forecast period can be attributed to factors such as the increasing prevalence of neurological disorders, greater public awareness, rising healthcare spending, growing investments in research and development, and an expansion in clinical research activities. Key trends in the forecast period include the adoption of novel drugs, the development of numerous new drugs, the emergence of innovative technologies, advancements in technology, and a rising demand for advanced products.

The growing prevalence of neurological disorders is expected to drive the expansion of the Huntington's disease market in the future. Neurological disorders are conditions that affect the brain, spinal cord, and nerves, resulting in symptoms such as movement, coordination, sensory, or cognitive impairments. The rise in these disorders can be attributed to factors such as aging populations, exposure to environmental toxins, lifestyle changes, advancements in diagnostic techniques, and genetic factors that enable better detection and identification of cases. Huntington's disease, a neurodegenerative disorder caused by a genetic mutation, leads to motor dysfunction, cognitive decline, and psychiatric symptoms, all of which progressively worsen over time. For example, in March 2023, the Alzheimer's Association, a U.S.-based nonprofit health organization, reported that an estimated 6.7 million Americans aged 65 and older are currently living with Alzheimer's dementia. Without breakthroughs to prevent, slow, or cure the disease, this number could increase to 13.8 million by 2060. This growing prevalence of neurological disorders is thus fueling the growth of the Huntington's disease market.

Companies in the Huntington's disease market are focusing on creating innovative treatments, including oral small molecule drugs, to alleviate symptoms and slow disease progression. These drugs are low-molecular-weight compounds that can be taken orally and are designed to interact with biological targets such as proteins or enzymes to treat diseases. For instance, in September 2024, PTC Therapeutics Inc., a U.S.-based pharmaceutical company, received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its PTC518 program, which targets Huntington's disease. This designation is given to therapies addressing significant unmet medical needs, underlining the potential of PTC518 as a disease-modifying treatment for individuals with this genetic disorder.

In December 2024, PTC Therapeutics, Inc. entered into a partnership with Novartis AG to expedite the development of PTC518 as an oral treatment for Huntington's disease. Novartis AG, a pharmaceutical company based in Switzerland, specializes in providing treatments such as branaplam (LMI070) for Huntington's disease.

Major players in the huntington's disease market are Novartis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Apotex Inc, Ipsen S.A., Vertex Pharmaceuticals Incorporated, H. Lundbeck A/S, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited., Neurocrine Biosciences Inc., Alnylam Pharmaceuticals Inc, PTC Therapeutics Inc., Annexon Inc., Voyager Therapeutics Inc., Stealth BioTherapeutics Corp., Vaccinex Inc., SOM Biotech S.L., Alterity Therapeutics Limited, and Medesis pharma SA.

North America was the largest region in the huntington's disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in huntington's disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the huntington's disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The huntington's disease market consists of revenues earned by entities by providing services such as medical management, psychological and social support, and physical, occupational, and speech therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The Huntington's disease market also includes sales of tetrabenazine, deutetrabenazine, and antidepressants. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Huntington's Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on huntington's disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for huntington's disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The huntington's disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Symptomatic Therapy; Disease-Modifying Therapy; Other Treatment Types
• 2) By Diagnosis: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; Genetic Testing; Other Diagnosis
• 3) By Route of Administration: Oral; Parenteral; Other Routes Of Administration
• 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Symptomatic Therapy: Antipsychotics; Antidepressants; Mood Stabilizers; Muscle Relaxants
• 2) By Disease-Modifying Therapy: Gene Silencing Therapies; Stem Cell Therapy; Neuroprotective Agents
• 3) By Other Treatment Types: Physical Therapy; Occupational Therapy; Speech Therapy
• Companies Mentioned: Novartis AG; Eli Lilly and Company; Teva Pharmaceutical Industries Ltd; Bausch Health Companies Inc.; Sun Pharmaceutical Industries Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Huntington's Disease Market Characteristics

3. Huntington's Disease Market Trends And Strategies

4. Huntington's Disease Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Huntington's Disease Growth Analysis And Strategic Analysis Framework

• 5.1. Global Huntington's Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Huntington's Disease Market Growth Rate Analysis
• 5.4. Global Huntington's Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Huntington's Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Huntington's Disease Total Addressable Market (TAM)

6. Huntington's Disease Market Segmentation

• 6.1. Global Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Symptomatic Therapy
• Disease-Modifying Therapy
• Other Treatment Types
• 6.2. Global Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT) Scan
• Genetic Testing
• Other Diagnosis
• 6.3. Global Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes Of Administration
• 6.4. Global Huntington's Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.5. Global Huntington's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users
• 6.6. Global Huntington's Disease Market, Sub-Segmentation Of Symptomatic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antipsychotics
• Antidepressants
• Mood Stabilizers
• Muscle Relaxants
• 6.7. Global Huntington's Disease Market, Sub-Segmentation Of Disease-Modifying Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Silencing Therapies
• Stem Cell Therapy
• Neuroprotective Agents
• 6.8. Global Huntington's Disease Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Therapy
• Occupational Therapy
• Speech Therapy

7. Huntington's Disease Market Regional And Country Analysis

• 7.1. Global Huntington's Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Huntington's Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Huntington's Disease Market

• 8.1. Asia-Pacific Huntington's Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Huntington's Disease Market

• 9.1. China Huntington's Disease Market Overview
• 9.2. China Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Huntington's Disease Market

• 10.1. India Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Huntington's Disease Market

• 11.1. Japan Huntington's Disease Market Overview
• 11.2. Japan Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Huntington's Disease Market

• 12.1. Australia Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Huntington's Disease Market

• 13.1. Indonesia Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Huntington's Disease Market

• 14.1. South Korea Huntington's Disease Market Overview
• 14.2. South Korea Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Huntington's Disease Market

• 15.1. Western Europe Huntington's Disease Market Overview
• 15.2. Western Europe Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Huntington's Disease Market

• 16.1. UK Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Huntington's Disease Market

• 17.1. Germany Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Huntington's Disease Market

• 18.1. France Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Huntington's Disease Market

• 19.1. Italy Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Huntington's Disease Market

• 20.1. Spain Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Huntington's Disease Market

• 21.1. Eastern Europe Huntington's Disease Market Overview
• 21.2. Eastern Europe Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Huntington's Disease Market

• 22.1. Russia Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Huntington's Disease Market

• 23.1. North America Huntington's Disease Market Overview
• 23.2. North America Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Huntington's Disease Market

• 24.1. USA Huntington's Disease Market Overview
• 24.2. USA Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Huntington's Disease Market

• 25.1. Canada Huntington's Disease Market Overview
• 25.2. Canada Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Huntington's Disease Market

• 26.1. South America Huntington's Disease Market Overview
• 26.2. South America Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Huntington's Disease Market

• 27.1. Brazil Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Huntington's Disease Market

• 28.1. Middle East Huntington's Disease Market Overview
• 28.2. Middle East Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Huntington's Disease Market

• 29.1. Africa Huntington's Disease Market Overview
• 29.2. Africa Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Huntington's Disease Market Competitive Landscape And Company Profiles

• 30.1. Huntington's Disease Market Competitive Landscape
• 30.2. Huntington's Disease Market Company Profiles
  • 30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Teva Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Huntington's Disease Market Other Major And Innovative Companies

• 31.1. Apotex Inc
• 31.2. Ipsen S.A.
• 31.3. Vertex Pharmaceuticals Incorporated
• 31.4. H. Lundbeck A/S
• 31.5. Dr. Reddy's Laboratories Ltd.
• 31.6. Hikma Pharmaceuticals PLC
• 31.7. Lupin Limited.
• 31.8. Neurocrine Biosciences Inc.
• 31.9. Alnylam Pharmaceuticals Inc
• 31.10. PTC Therapeutics Inc.
• 31.11. Annexon Inc.
• 31.12. Voyager Therapeutics Inc.
• 31.13. Stealth BioTherapeutics Corp.
• 31.14. Vaccinex Inc.
• 31.15. SOM Biotech S.L.

32. Global Huntington's Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Huntington's Disease Market

34. Recent Developments In The Huntington's Disease Market

35. Huntington's Disease Market High Potential Countries, Segments and Strategies

• 35.1 Huntington's Disease Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Huntington's Disease Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Huntington's Disease Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer